We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
Cap. Flow
-$3.22B
Cap. Flow %
-3.61%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.5%
4 Industrials 10.21%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
351
Novartis
NVS
$295B
$69.1M 0.08%
817,646
-18,139
-2% -$1.59M
INSM icon
352
Insmed
INSM
$23.2B
$69M 0.08%
3,499,010
+123,905
+4% +$2.6M
CNMD icon
353
CONMED
CNMD
$1.29B
$69M 0.08%
720,246
+14,392
+2% +$1.73M
SMTC icon
354
Semtech
SMTC
$11.7B
$68.8M 0.08%
1,251,537
+262,930
+27% +$15.9M
WK icon
355
Workiva
WK
$2.94B
$68.7M 0.08%
1,041,171
+76,809
+8% +$6.39M
SYF icon
356
Synchrony
SYF
$23.7B
$68.5M 0.08%
2,481,521
-330,570
-12% -$11.5M
GILD icon
357
Gilead Sciences
GILD
$161B
$68.3M 0.08%
1,105,561
-3,884
-0.4% -$240K
BDN
358
Brandywine Realty Trust
BDN
$551M
$68.3M 0.08%
7,080,744
+22,109
+0.3% +$249K
TSCO icon
359
Tractor Supply
TSCO
$16.3B
$68M 0.08%
1,753,625
-76,820
-4% -$3.12M
PTCT icon
360
PTC Therapeutics
PTCT
$6.37B
$67.7M 0.08%
1,688,734
+135,806
+9% +$4.76M
SUPN icon
361
Supernus Pharmaceuticals
SUPN
$2.68B
$67.6M 0.08%
2,337,304
+17,354
+0.7% +$497K
SHEL icon
362
Shell
SHEL
$245B
$67.2M 0.08%
1,285,589
-196,993
-13% -$11.1M
RARE icon
363
Ultragenyx Pharmaceutical
RARE
$2.65B
$66.3M 0.07%
1,110,561
+32,537
+3% +$2M
CBRL icon
364
Cracker Barrel
CBRL
$1.2B
$66.2M 0.07%
793,434
-154,605
-16% -$16.1M
ADNT icon
365
Adient
ADNT
$1.6B
$65.9M 0.07%
2,222,655
+325,234
+17% +$10.9M
ABT icon
366
Abbott
ABT
$180B
$65.6M 0.07%
603,991
-25,029
-4% -$2.84M
HLNE icon
367
Hamilton Lane
HLNE
$3.63B
$65.4M 0.07%
973,591
+35,527
+4% +$2.45M
SSTK icon
368
Shutterstock
SSTK
$205M
$65.4M 0.07%
1,140,635
+76,000
+7% +$5.09M
COR icon
369
Cencora
COR
$60.3B
$65M 0.07%
459,569
-26,113
-5% -$3.99M
BPMC
370
DELISTED
Blueprint Medicines
BPMC
$64.4M 0.07%
1,274,889
+41,961
+3% +$2.46M
NSA
371
DELISTED
National Storage Affiliates Trust
NSA
$64.2M 0.07%
1,281,719
+46,234
+4% +$2.52M
CPT icon
372
Camden Property Trust
CPT
$11.3B
$64.1M 0.07%
475,116
-4,661
-1% -$691K
DIOD icon
373
Diodes
DIOD
$4B
$63.8M 0.07%
988,748
+260,939
+36% +$19M
FND icon
374
Floor & Decor
FND
$5.81B
$63.8M 0.07%
1,013,186
+190,104
+23% +$14.3M
KIM icon
375
Kimco Realty
KIM
$17.6B
$63.3M 0.07%
3,197,266
+29,065
+0.9% +$668K

Similar funds

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.